These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Eumovate (clobetasone butyrate) 0.05% cream with its moisturizing emollient base has better healing properties than hydrocortisone 1% cream: a study in nickel-induced contact dermatitis. Parneix-Spake A; Goustas P; Green R J Dermatolog Treat; 2001 Dec; 12(4):191-7. PubMed ID: 12241627 [TBL] [Abstract][Full Text] [Related]
48. [Agents for skin protection from contaminants prepared with phenolformaldehyde and epoxy resin bases]. Farashchuk NF; Shulakov NA; Iasnetsov VS; Bozhefatov AS Gig Tr Prof Zabol; 1983 Sep; (9):52-3. PubMed ID: 6227531 [No Abstract] [Full Text] [Related]
49. Treatment of hyperkeratotic dermatitis of the palms. Sequential treatment with a keratolytic gel and corticosteroid ointment. Baden HP Arch Dermatol; 1974 Nov; 110(5):737-8. PubMed ID: 4424786 [No Abstract] [Full Text] [Related]
50. Allergic contact dermatitis from the perfume in mycolog cream. Goldberg HS Arch Dermatol; 1972 Jun; 105(6):896-7. PubMed ID: 5030239 [No Abstract] [Full Text] [Related]
51. [Atrophic changes in the skin from the use of corticosteroid ointments]. Somov BA; Markin IIa Sov Med; 1973 Apr; 36(4):137-8. PubMed ID: 4769996 [No Abstract] [Full Text] [Related]
52. [What is the best treatment for atopic dermatitis?]. Hannuksela M Duodecim; 2000; 116(21):2321-2. PubMed ID: 12053358 [No Abstract] [Full Text] [Related]
53. Clinical studies on the effectiveness of Wratizolin in the treatment of some dermatoses. Szarmach H; Wroński A; Laudańska H; Niczyporuk W Arch Immunol Ther Exp (Warsz); 1983; 31(5):655-61. PubMed ID: 6675573 [TBL] [Abstract][Full Text] [Related]
54. [The treatment of contact eczema by the internist and the general practitioner]. Krebs A Schweiz Med Wochenschr; 1966 Sep; 96(35):1133-5. PubMed ID: 5995224 [No Abstract] [Full Text] [Related]
55. Topical corticosteroids in eczema. A comparative trial. A report from the General Practitioner Research Group. Practitioner; 1981 Mar; 225(1353):410-1. PubMed ID: 7022434 [No Abstract] [Full Text] [Related]
56. [Preparation and testing of protective ointments containing Aerosil]. Gafiţanu E; Braha S; Nermin C Rev Med Chir Soc Med Nat Iasi; 1980; 84(3):553-8. PubMed ID: 6264562 [No Abstract] [Full Text] [Related]
57. [Treatment of seborrhoeic dermatitis]. Hannuksela M Duodecim; 1994; 110(12):1161-4. PubMed ID: 7497922 [No Abstract] [Full Text] [Related]
58. Allergy to bufexamac. Van Hecke E Arch Belg Dermatol; 1973; 29(4):301-3. PubMed ID: 4802391 [No Abstract] [Full Text] [Related]
59. [2-(4-Isobutylphenyl)-propionic acid in the topical treatment of venous and lymphatic inflammations. Comparative study and statistical evaluation of results]. Boselli G Minerva Med; 1974 Oct; 65(73):3829-34. PubMed ID: 4425546 [No Abstract] [Full Text] [Related]
60. A clinical evaluation of 0.05 per cent desonide cream. A new nonfluorinated topical corticosteroid. Gentry WC; Rosenberg EW; Goltz RW Arch Dermatol; 1973 Jun; 107(6):870-1. PubMed ID: 4575947 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]